Media Summary: Axel Grothey, M.D., discusses a new gene panel Presented By: Javier Hernandez-Losa Speaker Biography: Dr. Hernández Losa is Director of Molecular Biology Laboratory in the ... Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the choices for genetic testing in metastatic non–small cell lung

Ngs For Actionable Mutations Detection In Solid And Liquid Tumors Protocol Preview - Detailed Analysis & Overview

Axel Grothey, M.D., discusses a new gene panel Presented By: Javier Hernandez-Losa Speaker Biography: Dr. Hernández Losa is Director of Molecular Biology Laboratory in the ... Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the choices for genetic testing in metastatic non–small cell lung Precision medicine promises a more effective approach to disease treatment and management. It is based on analyzing Luis Montuenga, MD, Clinica Universidad de Navarra, Pamplona, Spain, talks on the advances in genetic testing for Presented By: Monika Seidel Speaker Biography: Monika Seidel is the scientific lead on new product development from ...

The discovery and validation of biomarkers in In the past, we have used drugs or other modalities to treat Dr. Jack West reviews the implications, both encouraging and potentially detrimental, of a recent FDA approval for broad genomic ... In this webinar, you'll learn how comprehensive Robin Cornelissen, MD, PhD, Erasmus University Rotterdam, Rotterdam, Netherlands, explains how the introduction of ...

Photo Gallery

NGS for Actionable Mutations Detection in Solid and Liquid Tumors | Protocol Preview
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
CtDNA Mutations Detection by  Next Generation Sequencing (NGS) | Protocol Preview
Next Generation Sequencing Panel for Solid Tumor Cancers - A Test in Focus
Advancing pathology and cancer research with next-generation sequencing   | Illumina Video
NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine
NGS evolution in Solid Tumours, from S5-XL to Genexus
Liquid Biopsy and Next-Generation Sequencing
Emerging Role of Liquid Biopsies and NGS for Biomarker Discovery
The advances and limitations of genetic testing for actionable mutations
Detection of mutations from liquid biopsies - applications in cancer diagnostics
liquiCŌREprime Next Generation Sequencing Liquid Biopsy Panel
View Detailed Profile
NGS for Actionable Mutations Detection in Solid and Liquid Tumors | Protocol Preview

NGS for Actionable Mutations Detection in Solid and Liquid Tumors | Protocol Preview

Watch the Full Video at ...

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

An Open Access

CtDNA Mutations Detection by  Next Generation Sequencing (NGS) | Protocol Preview

CtDNA Mutations Detection by Next Generation Sequencing (NGS) | Protocol Preview

Watch the Full Video at ...

Next Generation Sequencing Panel for Solid Tumor Cancers - A Test in Focus

Next Generation Sequencing Panel for Solid Tumor Cancers - A Test in Focus

Axel Grothey, M.D., discusses a new gene panel

Advancing pathology and cancer research with next-generation sequencing   | Illumina Video

Advancing pathology and cancer research with next-generation sequencing | Illumina Video

NGS

NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine

NGS Testing for Solid Tumors: How It Works at HNL Lab Medicine

At HNL Lab Medicine, we provide

NGS evolution in Solid Tumours, from S5-XL to Genexus

NGS evolution in Solid Tumours, from S5-XL to Genexus

Presented By: Javier Hernandez-Losa Speaker Biography: Dr. Hernández Losa is Director of Molecular Biology Laboratory in the ...

Liquid Biopsy and Next-Generation Sequencing

Liquid Biopsy and Next-Generation Sequencing

Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the choices for genetic testing in metastatic non–small cell lung

Emerging Role of Liquid Biopsies and NGS for Biomarker Discovery

Emerging Role of Liquid Biopsies and NGS for Biomarker Discovery

Precision medicine promises a more effective approach to disease treatment and management. It is based on analyzing

The advances and limitations of genetic testing for actionable mutations

The advances and limitations of genetic testing for actionable mutations

Luis Montuenga, MD, Clinica Universidad de Navarra, Pamplona, Spain, talks on the advances in genetic testing for

Detection of mutations from liquid biopsies - applications in cancer diagnostics

Detection of mutations from liquid biopsies - applications in cancer diagnostics

Presented By: Monika Seidel Speaker Biography: Monika Seidel is the scientific lead on new product development from ...

liquiCŌREprime Next Generation Sequencing Liquid Biopsy Panel

liquiCŌREprime Next Generation Sequencing Liquid Biopsy Panel

liquiCŌREprime

Unlocking the potential of ultra-low frequency variant identification for cancer research

Unlocking the potential of ultra-low frequency variant identification for cancer research

The discovery and validation of biomarkers in

How Next Generation Sequencing can optimize treatment options for patients with solid tumors

How Next Generation Sequencing can optimize treatment options for patients with solid tumors

In the past, we have used drugs or other modalities to treat

Advances in Cancer Diagnosis using NGS - Webinar English 24/03

Advances in Cancer Diagnosis using NGS - Webinar English 24/03

Get to know the latest tests using

Raed Samara - Next generation sequencing for BRCA1 and BRCA2 mutation testing

Raed Samara - Next generation sequencing for BRCA1 and BRCA2 mutation testing

Watch on LabRoots at http://labroots.com/webcast/id/653

Utilization of NGS to Identify Mutations in cfDNA: Meet the NGS Experts Series Part 3

Utilization of NGS to Identify Mutations in cfDNA: Meet the NGS Experts Series Part 3

Pancreatic

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us? (BMIC-019)

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us? (BMIC-019)

Dr. Jack West reviews the implications, both encouraging and potentially detrimental, of a recent FDA approval for broad genomic ...

Adopting NGS for Tumor Profiling: Accessible Sequencing. Flexible  Solutions | Illumina Webinar

Adopting NGS for Tumor Profiling: Accessible Sequencing. Flexible Solutions | Illumina Webinar

In this webinar, you'll learn how comprehensive

NGS for the detection of mutations in NSCLC

NGS for the detection of mutations in NSCLC

Robin Cornelissen, MD, PhD, Erasmus University Rotterdam, Rotterdam, Netherlands, explains how the introduction of ...